Categories AlphaGraphs, Earnings, Health Care
BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results
Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also provided guidance for fiscal 2023.
Net income attributable to shareholders was $1.93 billion or $0.93 per share in the September quarter, compared to $1.61 billion or $0.75 per share in the comparable period of 2022. Adjusted profit edged up to $2.0 per share in Q3 from $1.99 per share in the prior year period.
Third-quarter revenues decreased 2% from last year to $10.97 billion. Domestic revenues declined by 4%, while international revenues moved up 2%.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Important takeaways from Broadcom’s (AVGO) Q4 2023 earnings
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) ended fiscal 2023 on a positive note, delivering strong results for the fourth quarter. In the new fiscal year, the company’s focus will be
Here’s what Signet Jewelers (SIG) expects for the holiday season and beyond
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 2% on Friday. The stock has gained 40% year-to-date and 27% over the past three months. The jewelry retailer saw
DOCU Earnings: DocuSign Q3 2024 revenue up 9%; profit beats estimates
eSignature service provider DocuSign, Inc. (NASDAQ: DOCU) reported higher revenues and better-than-expected adjusted earnings for the third quarter of 2024. The company also provided guidance for the fourth quarter and
